Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

70.23
BATS BZX Real-Time Price
As of 1:43pm ET
 -0.25 / -0.35%
Today’s Change
63.76
Today|||52-Week Range
88.85
-1.93%
Year-to-Date
Stock Market News for June 23, 2017
12:03pm / Zacks.com - Paid Partner Content
Is Gilead Sciences on the Verge of a Powerful Rally Leg?
Jun 21 / TheStreet.com - Paid Partner Content
2 Recovering Biotech Names With Room to Run
11:33am / TheStreet.com - Paid Partner Content
Pharma recovers composure as price concerns ease
Jun 21 / FT.com - Paid Partner Content
Why Gilead Sciences Is Nearing Yet Another Mind-Bending Breakout
8:03am / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt
Jun 21 / Zacks.com - Paid Partner Content
The Market Advance Narrows
Jun 22 / TheStreet.com - Paid Partner Content
Gilead's (GILD) HBV Drug Vemlidy Receives Approval in Canada
Jun 20 / Zacks.com - Paid Partner Content
How to Find the Best Value Stocks
Jun 21 / Zacks.com - Paid Partner Content
Where to Find Value in a Lofty Market
Jun 16 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close70.48
Today’s open70.48
Day’s range69.93 - 71.37
Volume1,162,799
Average volume (3 months)8,525,832
Market cap$92.1B
Dividend yield2.96%
Data as of 1:43pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-29.70%
Earnings growth (next 5 years)-1.00%
Revenue growth (last year)-5.37%
P/E ratio7.4
Price/Sales3.21
Price/Book4.89

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+0.22+0.08%
AMGNAmgen-1.75-1.01%
ILMNIllumina Inc+0.78+0.43%
BIVVBioverativ Inc+0.65+1.07%
Data as of 1:43pm ET, 06/23/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$2.10
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts